Where COVID-19 is hitting state economies the hardest

Louisiana is the most exposed state economy when it comes to the new coronavirus, COVID-19.

The COVID-19 pandemic has caused significant economic disruptions, with the stock market dropping about 20% and unemployment soaring.

That’s according to WalletHub, which ranked states across 10 key metrics, looking at the share of employment by small businesses, the share of GDP from highly affected industries in a state, and unemployment claims.

While Louisiana was the most exposed state overall, Rhode Island actually saw the highest increase in the number of initial unemployment insurance claims, at 4,574.93% in the 12th week of 2020 compared to the same time period in 2019. Utah, which had the lowest increase in unemployment insurance claims, saw a 50.52% increase.

Here are the top 10 states with most exposed economies:

  • Louisiana
  • Rhode Island
  • Nevada
  • Maine
  • New Hampshire
  • Pennsylvania
  • Montana
  • New Jersey
  • Massachusetts
  • Illinois

Mississippi, Louisiana, Alabama, West Virginia and Arkansas had the lowest share of workers working from home. Several states and businesses have shifted to working from home to keep people from congregating at office buildings and spreading the virus.

Here are the states with the least exposed economies

  • Arkansas
  • Nebraska
  • Alabama
  • South Dakota
  • Utah
  • Oregon
  • Alaska
  • California
  • Georgia

See the full report here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.